Abstract
The objective of this chapter is to review strategies for management of genito-pelvic pain/penetration disorder (GPPPD). GPPPD refers to pain or fear of pain with sexual genital contact or vaginal penetration. This broad diagnosis demands a comprehensive evaluation and a multiplatform management strategy. GPPPD is commonly associated with specific diagnoses including localized vulvodynia, vulvar dermatoses, hormonally related atrophy, neuropathy, vaginismus, pelvic floor hypertonus and myalgia, and chronic pelvic pain conditions such as endometriosis and bladder pain syndromes. Typically, multiple diagnoses underlie dyspareunia. Treatment is dependent on identification of all components of pain. Psychological, interpersonal, and cultural dynamics must be addressed. Multidisciplinary management generally combines medication, physical therapy, psychological therapy, and when indicated, surgery. This chapter presents evidence-based treatment modalities for each of the conditions commonly associated with GPPPD.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
American Psychiatric Association. Diagnostic and statistical manuel of mental disorders (5th ed., Text Rev). Washington: American Psychiatric Association; 2013.
Bergeron S, Corsini-Munt S, Aerts L, Rancourt K, Rosen N. Female sexual pain disorders: a review of the literature on etiology and treatment. Curr Sex Health Rep. 2015;7(3):159–69.
Bornstein J, Goldstein AT, Stockdale CK, Bergeron S, Pukall C, Zolnoun D, Coady D. Consensus vulvar pain terminology committee of the International Society for the Study of Vulvovaginal Disease (ISSVD), the International Society for the Study of Womenʼs Sexual Health (ISSWSH), and the International Pelvic Pain Society (IPPS). Obstet Gynecol. 2016;127(4):745–51. doi:10.1097/AOG.0000000000001359.
Harlow BL, Kunitz CG, Nguyen RH, Rydell SA, Turner RM, MacLehose RF. Prevalence of symptoms consistent with a diagnosis of vulvodynia: population-based estimates from 2 geographic regions. Am J Obstet Gynecol. 2014;210(1):40.
Pukall CF, Goldstein AT, Bergeron S, Foster D, Stein A, Kellogg-Spadt S, Bachmann G. Vulvodynia: definition, prevalence, impact, and pathophysiological factors. J Sex Med. 2016;13(3):291–304. doi:10.1016/j.jsxm.2015.12.021.
American College of Obstetricians and Gynecologists Committee Opinion. Persistent vulvar pain. Number 673, September 2016;128:78–84.
Lamvu G, Nguyen RH, Burrows LJ, Rapkin A, Witzeman K, Marvel RP, Hutchins D, Witkin SS, Veasley C, Fillingim R, Zolnoun D. The evidence-based vulvodynia assessment project. A national registry for the study of vulvodynia. The evidence-based vulvodynia assessment project. A national registry for the study of vulvodynia. J Reprod Med. 2015;60(5–6):223–35.
Sarton J. Assessment of the pelvic floor muscles in women with sexual pain. J Sex Med. 2010;7:3526–9.
Al-Abbadey M, Liossi C, Curran N, Schoth DE, Graham CA. Treatment of female sexual pain disorders: a systematic review. J Sex Marital Ther. 2016;42(2):99–142. doi:10.1080/0092623X.2015.1053023.. Epub 2015 Jun 2.
Goldstein AT, Pukall CF, Brown C, Bergeron S, Stein A, Kellogg-Spadt S. Vulvodynia: assessment and treatment. J Sex Med. 2016;13(4):572–90. doi:10.1016/j.jsxm.2016.01.020.. Epub 2016 Mar 25.
Landry T, Bergeron S, Dupuis MJ, Desrochers G. The treatment of provoked vestibulodynia: a critical review. Clin J Pain. 2008;24(2):155–71. doi:10.1097/AJP.0b013e31815aac4d.
Sadownik LA. Etiology, diagnosis, and clinical management of vulvodynia. Int J Womens Health. 2014;6:437–49.
Yong PJ, Sadownik L, Brotto LA. Concurrent deep-superficial dyspareunia: prevalence, associations, and outcomes in a multidisciplinary vulvodynia program. J Sex Med. 2015;12(1):219–27.
De Andres J, Sanchis-Lopez N, Asensio-Samper JM, Fabregat-Cid G, Villanueva-Perez VL, Monsalve Dolz V, Minguez A. Vulvodynia—an evidence-based literature review and proposed treatment algorithm. Pain Pract. 2016;16(2):204–36. doi:10.1111/papr.12274.. Epub 2015 Jan 12.
Goetsch MF. Surgery combined with muscle therapy for dyspareunia from vulvar vestibulitis: an observational study. J Reprod Med. 2007;52(7):597–603.
Baggish MS, Miklos JR. Vulvar pain syndrome: a review. Obstet Gynecol Surv. 1995;50(8):618–27.
Andrews JC. Vulvodynia interventions—systematic review and evidence grading. Obstet Gynecol Surv. 2011;66(5):299–315.
Tommola P, Unkila-Kallio L, Paavonen J. Surgical treatment of vulvar vestibulitis: a review. Acta Obstet Gynecol Scand. 2010;89(11):1385–95. doi:10.3109/00016349.2010.512071.
Woodruff JD, Genadry R, Poliakoff S. Treatment of dyspareunia and vaginal outlet distortions by perineoplasty. Obstet Gynecol. 1981;57(6):750–4.
Bohm-Starke N, Rylander E. Surgery for localized, provoked vestibulodynia: a long-term follow-up study. J Reprod Med. 2008;53(2):83–9.
Bergeron S, Binik Y, Khalifé S, Pagidas K, Glazer H. A randomized comparison of group cognitive–behavioral therapy, surface electromyographic biofeedback, and vestibulectomy in the treatment of dyspareunia resulting from vulvar vestibulitis. Pain. 2001;91(3):297–306. doi:10.1016/S0304-3959(00)00449-8.
Tommola P, Unkila-Kallio L, Paavonen J. Long-term well-being after surgical or conservative treatment of severe vulvar vestibulitis. Acta Obstet Gynecol Scand. 2012;91(9):1086–93. doi:10.1111/j.1600-0412.2012.01466.x.. Epub 2012 Jul 2.
Nunns D, Mandal D, Byrne M, McLelland J, Rani R, Cullimore J, Bansal D, Brackenbury F, Kirtschig G, Wier M. British Society for the Study of Vulval Disease (BSSVD) guideline group. guidelines for the management of vulvodynia. Br J Dermatol. 2010;162(6):1180–5. doi:10.1111/j.1365-2133.2010.09684.x.. Epub 2010 Mar 16.
Reed BD, Haefner HK, Sen A, Gorenflo DW. Vulvodynia incidence and remission rates among adult women: a 2-year follow-up study. Obstet Gynecol. 2008;112(2 Pt 1):231–7. doi:10.1097/AOG.0b013e318180965b.
Foster DC, Kotok MB, Huang LS, Watts A, Oakes D, Howard FM, Poleshuck EL, Stodgell CJ, Dworkin RH. Oral desipramine and topical lidocaine for vulvodynia: a randomized controlled trial. Obstet Gynecol. 2010;116(3):583–93. doi:10.1097/AOG.0b013e3181e9e0ab.
Brown CS, Wan J, Bachmann G, Rosen R. Self-management, amitriptyline, and amitripyline plus triamcinolone in the management of vulvodynia. J Womens Health (Larchmt). 2009;18(2):163–9. doi:10.1089/jwh.2007.0676.
Reed BD, Caron AM, Gorenflo DW, Haefner HK. Treatment of vulvodynia with tricyclic antidepressants: efficacy and associated factors. J Low Genit Tract Dis. 2006;10(4):245–51.
Pagano R, Wong S. Use of amitriptyline cream in the management of entry dyspareunia due to provoked vestibulodynia. J Low Genit Tract Dis. 2012;16(4):394–7. doi:10.1097/LGT.0b013e3182449bd6.
Leo RJ, Dewani S. A systematic review of the utility of antidepressant pharmacotherapy in the treatment of vulvodynia pain. J Sex Med. 2013;10(10):2497–505. doi:10.1111/j.1743-6109.2012.02915.x.. Epub 2012 Sep 13.
Boardman LA, Cooper AS, Blais LR, Raker CA. Topical gabapentin in the treatment of localized and generalized vulvodynia. Obstet Gynecol. 2008;112(3):579–85. doi:10.1097/AOG.0b013e3181827c77.
Bergeron S, Khalifé S, Glazer H, Binik Y. Surgical and behavioral treatments for vestibulodynia: two-and-one-half-year follow-up and predictors of outcome. Obstet Gynecol. 2008;111(1):159–66. doi:10.1097/01.AOG.0000295864.76032.a7.
Danielsson I, Torstensson T, Brodda-Jansen G, Bohm-Starke N. EMG biofeedback versus topical lidocaine gel: a randomized study for the treatment of women with vulvar vestibulitis. Acta Obstet Gynecol Scand. 2006;85(11):1360–7.
Zolnoun DA, Hartmann KE, Steege JF. Overnight 5% lidocaine ointment for treatment of vulvar vestibulitis. Obstet Gynecol. 2003;102(1):84–7.
Segal D, Tifheret H, Lazer S. Submucous infiltration of betamethasone and lidocaine in the treatment of vulvar vestibulitis. Eur J Obstet Gynecol Reprod Biol. 2003 Mar 26;107(1):105–6.
Murina F, Tassan P, Roberti P, Bianco V. Treatment of vulvar vestibulitis with submucous infiltrations of methylprednisolone and lidocaine. An alternative approach. J Reprod Med. 2001;46(8):713–6.
McDonald JS, Rapkin AJ. Multilevel local anesthetic nerve blockade for the treatment of generalized vulvodynia: a pilot study. J Sex Med. 2012;9(11):2919–26. doi:10.1111/j.1743-6109.2012.02909.x.. Epub 2012 Aug 27.
Rapkin AJ, McDonald JS, Morgan M. Multilevel local anesthetic nerve blockade for the treatment of vulvar vestibulitis syndrome. Am J Obstet Gynecol. 2008;198(1):41.e1–5 .Epub 2007 Oct 22
Abbott J. The use of botulinum toxin in the pelvic floor for women with chronic pelvic pain-a new answer to old problems? J Minim Invasive Gynecol. 2009;16(2):130–5. doi:10.1016/j.jmig.2008.11.006.. Epub 2009 Jan 22. Review.
Petersen CD, Giraldi A, Lundvall L, Kristensen E. Botulinum toxin type A-a novel treatment for provoked vestibulodynia? Results from a randomized, placebo controlled, double blinded study. J Sex Med. 2009;6(9):2523–37. doi:10.1111/j.1743-6109.2009.01378.x.. Epub 2009 Jul 10.
Abbott JA, Jarvis SK, Lyons SD, Thomson A, Vancaille TG. Botulinum toxin type A for chronic pain and pelvic floor spasm in women: a randomized controlled trial. Obstet Gynecol. 2006;108(4):915–23.
Bosso JV, Aiken MJ, Simon RA. Successful prevention of local and cutaneous hypersensitivity reactions to seminal fluid with intravaginal cromolyn. Allergy Proc. 1991;12(2):113–6.
Nyirjesy P, Sobel JD, Weitz MV, Leaman DJ, Small MJ, Gelone SP. Cromolyn cream for recalcitrant idiopathic vulvar vestibulitis: results of a placebo controlled study. Sex Transm Infect. 2001;77(1):53–7.
Murina F, Radici G, Bianco V. Capsaicin and the treatment of vulvar vestibulitis syndrome: a valuable alternative? MedGenMed. 2004;6(4):48.
Steinberg AC, Oyama IA, Rejba AE, Kellogg-Spadt S, Whitmore KE. Capsaicin for the treatment of vulvar vestibulitis. Am J Obstet Gynecol. 2005;192(5):1549–53.
Bouchard C, Brisson J, Fortier M, Morin C, Blanchette C. Use of oral contraceptive pills and vulvar vestibulitis: a case-control study. Am J Epidemiol. 2002;156(3):254–61.
Edgardh K, Abdelnoor M. Vulvar vestibulitis and risk factors: a population-based case-control study in Oslo. Acta Derm Venereol. 2007;87(4):350–4.
Lee M, Morgan M, Rapkin A. Clitoral and vulvar vestibular sensation in women taking 20 mcg ethinyl estradiol combined oral contraceptives: a preliminary study. J Sex Med. 2011;8(1):213–8. doi:10.1111/j.1743-6109.2010.02074.x.. Epub 2010 Oct 18.
Burrows LJ, Goldstein AT. The treatment of vestibulodynia with topical estradiol and testosterone. Sex Med. 2013;1(1):30–3. doi:10.1002/sm2.4.
Goldstein A, Burrows L, Goldstein I. Can oral contraceptives cause vestibulodynia? J Sex Med. 2010;7(4 Pt 1):1585–7.
Simonelli C, Eleuteri S, Petruccelli F, Rossi R. Female sexual pain disorders: dyspareunia and vaginismus. Curr Opin Psychiatry. 2014;27(6):406–12.
Reissing ED, Brown C, Lord MJ, Binik YM, Khalifé S. Pelvic floor muscle functioning in women with vulvar vestibulitis syndrome. J Psychosom Obstet Gynaecol. 2005;26(2):107–13.
Bortolami A, Vanti C, Banchelli F, Guccione AA, Pillastrini P. Relationship between female pelvic floor dysfunction and sexual dysfunction: an observational study. J Sex Med. 2015;12(5):1233–41. doi:10.1111/jsm.12882.. Epub 2015 Apr 8.
Albrecht KB. “How-To” guide to pelvic floor muscle dysfunction. Clin Obstet Gynecol. 2015;58(3):546–50. doi:10.1097/GRF.0000000000000135.
Hong CZ, Simons DG. Pathophysiologic and electrophysiologic mechanisms of myofascial trigger points. Arch Phys Med Rehabil. 1998;79(7):863–72.
Haefner HK, Collins ME, Davis GD, Edwards L, Foster DC, Hartmann ED, Kaufman RH, Lynch PJ, Margesson LJ, Moyal-Barracco M, Piper CK, Reed BD, Stewart EG, Wilkinson EJ. The vulvodynia guideline. J Low Genit Tract Dis. 2005;9(1):40–51.
Goldfinger C, Pukall CF, Gentilcore-Saulnier E, McLean L, Chamberlain S. A prospective study of pelvic floor physical therapy: pain and psychosexual outcomes in provoked vestibulodynia. J Sex Med. 2009;6(7):1955–68.
Goldfinger C, Pukall CF, Thibault-Gagnon S, McLean L, Chamberlain S. Effectiveness of cognitive-behavioral therapy and physical therapy for provoked vestibulodynia: a randomized pilot study. J Sex Med. 2016;13(1):88–94.
Gentilcore-Saulnier E, McLean L, Goldfinger C, Pukall CF, Chamberlain S. Pelvic floor muscle assessment outcomes in women with and without provoked vestibulodynia and the impact of a physical therapy program. J Sex Med. 2010;7(2 Pt 2).
Bergeron S, Brown C, Lord MJ, Oala M, Binik YM, Khalifé S. Physical therapy for vulvar vestibulitis syndrome: a retrospective study. J Sex Marital Ther. 2002;28(3):183–92.
Glazer HI, Rodke G, Swencionis C, Hertz R, Young AW. Treatment of vulvar vestibulitis syndrome with electromyographic biofeedback of pelvic floor musculature. J Reprod Med. 1995;40(4):283–90.
Glazer HI. Dysesthetic vulvodynia. Long-term follow-up after treatment with surface electromyography-assisted pelvic floor muscle rehabilitation. J Reprod Med. 2000;45(10):798–802.
McKay E, Kaufman RH, Doctor U, Berkova Z, Glazer H, Redko V. Treating vulvar vestibulitis with electromyographic biofeedback of pelvic floor musculature. J Reprod Med. 2001;46(4):337–42.
Murina F, Bianco V, Radici G, Felice R, Di Martino M, Nicolini U. Transcutaneous electrical nerve stimulation to treat vestibulodynia: a randomised controlled trial. BJOG. 2008;115(9):1165–70. doi:10.1111/j.1471-0528.2008.01803.x.
Desrochers G, Bergeron S, Khalifé S, Dupuis MJ, Jodoin M. Fear avoidance and self-efficacy in relation to pain and sexual impairment in women with provoked vestibulodynia. Clin J Pain. 2009;25(6):520–7. doi:10.1097/AJP.0b013e31819976e3.
Maillé DL, Bergeron S, Lambert B. Body image in women with primary and secondary provoked vestibulodynia: a controlled study. J Sex Med. 2015;12(2):505–15. doi:10.1111/jsm.12765.. Epub 2014 Nov 13.
Desrochers G, Bergeron S, Landry T, Jodoin M. Do psychosexual factors play a role in the etiology of provoked vestibulodynia? A critical review. J Sex Marital Ther. 2008;34(3):198–226. doi:10.1080/00926230701866083.
Smith KB, Pukall CF. A systematic review of relationship adjustment and sexual satisfaction among women with provoked vestibulodynia. J Sex Res. 2011;48(2–3):166–91. doi:10.1080/00224499.2011.555016.
Pâquet M, Bois K, Rosen NO, Mayrand MH, Charbonneau-Lefebvre V, Bergeron S. Why us? perceived injustice is associated with more sexual and psychological distress in couples coping with genito-pelvic pain. J Sex Med. 2016;13(1):79–87. doi:10.1016/j.jsxm.2015.11.007.
Jackson B, Kubzansky L, Wright R, Rosalind J. Linking perceived unfairness to physical health: the perceived unfairness model. Rev Gen Psychol. 2006;10(1):21–40. doi:10.1037/1089-2680.10.1.21.
Rosenbaum TY, Barnard E, Wilhite M. Psychosexual aspects of vulvar disease. Clin Obstet Gynecol. 2015;58(3):551–5. doi:10.1097/GRF.0000000000000136.
Masheb RM, Kerns RD, Lozano C, Minkin MJ, Richman S. A randomized clinical trial for women with vulvodynia: cognitive-behavioral therapy vs. supportive psychotherapy. Pain. 2009;141(1–2):31–40. doi:10.1016/j.pain.2008.09.031.. Epub 2008 Nov 20.
Desrochers G, Bergeron S, Khalifé S, Dupuis MJ, Jodoin M. Provoked vestibulodynia: psychological predictors of topical and cognitive-behavioral treatment outcome. Behav Res Ther. 2010;48(2):106–15. doi:10.1016/j.brat.2009.09.014.. Epub 2009 Oct 7.
Corsini-Munt S, Bergeron S, Rosen NO, Mayrand MH, Delisle I. Feasibility and preliminary effectiveness of a novel cognitive-behavioral couple therapy for provoked vestibulodynia: a pilot study. J Sex Med. 2014;11(10):2515–27.
Lindström S, Kvist LJ. Treatment of provoked vulvodynia in a Swedish cohort using desensitization exercises and cognitive behavioral therapy. BMC Womens Health. 2015;15:108. doi:10.1186/s12905-015-0265-3.
Weijmar Schultz WC, Gianotten WL, van der Meijden WI, van de Wiel HB, Blindeman L, Chadha S, Drogendijk AC. Behavioral approach with or without surgical intervention to the vulvar vestibulitis syndrome: a prospective randomized and non-randomized study. J Psychosom Obstet Gynaecol. 1996;17(3):143–8.
Bishop S, Lau M, Shapiro S, Carlson L, Anderson N, Carmody J, Segal Z, Abbey S, Specca M, Velging D, Devins G. Mindfulness: a proposed operational definition. Clin Psychol. 2004;11(3):230–41. doi:10.1093/clipsy.bph077.
Brotto LA, Basson R. Group mindfulness-based therapy significantly improves sexual desire in women. Behav Res Ther. 2014;57:43–54. doi:10.1016/j.brat.2014.04.001.. Epub 2014 Apr 18.
Brotto L, Basson R, Smith K, Driscoll M, Sadownik L. Mindfulness-based Group therapy for women with provoked vestibulodynia. Mindfulness. 2015;6(3):417–32.
Pukall C, Kandyba K, Amsel R, Khalifé S, Binik Y. Effectiveness of hypnosis for the treatment of vulvar vestibulitis syndrome: a preliminary investigation. J Sex Med. 2007;4(2):417–25.
Rosen NO, Bergeron S, Leclerc B, Lambert B, Steben M. Woman and partner-perceived partner responses predict pain and sexual satisfaction in provoked vestibulodynia (PVD) couples. J Sex Med. 2010;7(11):3715–24. doi:10.1111/j.1743-6109.2010.01957.x.
Sheppard C, Hallam-Jones R, Wylie K. Why have you both come? Emotional, relationship, sexual and social issues raised by heterosexual couples seeking sexual therapy (in women referred to a sexual difficulties clinic with a history of vulval pain). Sex Relat Ther. 2008;23(3):217–26. doi:10.1080/14681990802227974.
Awada N, Bergeron S, Steben M, Hainault VA, McDuff P. To say or not to say: dyadic ambivalence over emotional expression and its associations with pain, sexuality, and distress in couples coping with provoked vestibulodynia. J Sex Med. 2014;11(5):1271–82. doi:10.1111/jsm.12463.. Epub 2014 Feb 19.
Desrosiers M, Bergeron S, Meana M, Leclerc B, Binik YM, Khalifé S. Psychosexual characteristics of vestibulodynia couples: partner solicitousness and hostility are associated with pain. J Sex Med. 2008;5(2):418–27 .Epub 2007 Dec 17
Lemieux AJ, Bergeron S, Steben M, Lambert B. Do romantic partners’ responses to entry dyspareunia affect women’s experience of pain? The roles of catastrophizing and self-efficacy. J Sex Med. 2013;10(9):2274–84. doi:10.1111/jsm.12252.. Epub 2013 Jun 27.
Rosen NO, Bergeron S, Glowacka M, Delisle I, Baxter ML. Harmful or helpful: perceived solicitous and facilitative partner responses are differentially associated with pain and sexual satisfaction in women with provoked vestibulodynia. J Sex Med. 2012;9(9):2351–60. doi:10.1111/j.1743-6109.2012.02851.x.. Epub 2012 Jul 19.
Bois K, Bergeron S, Rosen NO, McDuff P, Grégoire C. Sexual and relationship intimacy among women with provoked vestibulodynia and their partners: associations with sexual satisfaction, sexual function, and pain self-efficacy. J Sex Med. 2013;10(8):2024–35. doi:10.1111/jsm.12210.. Epub 2013 Jun 26.
Boerner KE, Rosen NO. Acceptance of vulvovaginal pain in women with provoked vestibulodynia and their partners: associations with pain, psychological, and sexual adjustment. J Sex Med. 2015;12(6):1450–62. doi:10.1111/jsm.12889.. Epub 2015 Apr 13.
Rosen NO, Bergeron S, Sadikaj G, Delisle I. Daily associations among male partner responses, pain during intercourse, and anxiety in women with vulvodynia and their partners. J Pain. 2015;16(12):1312–20. doi:10.1016/j.jpain.2015.09.003.. Epub 2015 Sep 25.
Corsini-Munt S, Bergeron S, Rosen NO, Steben M, Mayrand MH, Delisle I, McDuff P, Aerts L, Santerre-Baillargeon M. A comparison of cognitive-behavioral couple therapy and lidocaine in the treatment of provoked vestibulodynia: study protocol for a randomized clinical trial. Trials. 2014;15:506.
Schlaeger JM, Xu N, Mejta CL, Park CG, Wilkie DJ. Acupuncture for the treatment of vulvodynia: a randomized wait-list controlled pilot study. J Sex Med. 2015;12(4):1019–27. doi:10.1111/jsm.12830.. Epub 2015 Jan 30.
Backman H, Widenbrant M, Bohm-Starke N, Dahlof LG. Combined physical and psychosexual therapy for provoked vestibulodynia-an evaluation of a multidisciplinary treatment model. J Sex Res. 2008;45(4):378–85. doi:10.1080/00224490802398365.
Spoelstra SK, Dijkstra JR, van Driel MF, Weijmar Schultz WC. Long-term results of an individualized, multifaceted, and multidisciplinary therapeutic approach to provoked vestibulodynia. J Sex Med. 2011;8(2):489–96. doi:10.1111/j.1743-6109.2010.01941.x.
Brotto LA, Yong P, Smith KB, Sadownik LA. Impact of a multidisciplinary vulvodynia program on sexual functioning and dyspareunia. J Sex Med. 2015;12(1):238–47. doi:10.1111/jsm.12718.. Epub 2014 Oct 30.
Lahaie MA, Amsel R, Khalifé S, Boyer S, Faaborg-Andersen M, Binik YM. Can fear, pain, and muscle tension discriminate vaginismus from dyspareunia/provoked vestibulodynia? Implications for the new DSM-5 diagnosis of genito-pelvic pain/penetration disorder. Arch Sex Behav. 2015;44(6):1537–50. doi:10.1007/s10508-014-0430-z.. Epub 2014 Nov 15.
Pacik PT. Understanding and treating vaginismus: a multimodal approach. Int Urogynecol J. 2014;25(12):1613–20. doi:10.1007/s00192-014-2421-y.. Epub 2014 Jun 4.
Shifren JL, Johannes CB, Monz BU, Russo PA, Bennett L, Rosen R. Help-seeking behavior of women with self-reported distressing sexual problems. J Womens Health (Larchmt). 2009;18(4):461–8. doi:10.1089/jwh.2008.1133.
Melnik T, Hawton K, McGuire H. Interventions for vaginismus. Cochrane Database Syst Rev. 2012;12:CD001760. doi:10.1002/14651858.CD001760.pub2.
Pacik PT. Vaginismus: review of current concepts and treatment using botox injections, bupivacaine injections, and progressive dilation with the patient under anesthesia. Aesthetic Plast Surg. 2011;35(6):1160–4. doi:10.1007/s00266-011-9737-5.. Epub 2011 May 10. Review.
Macey K, Gregory A, Nunns D, das Nair R. Women’s experiences of using vaginal trainers (dilators) to treat vaginal penetration difficulties diagnosed as vaginismus: a qualitative interview study. BMC Womens Health. 2015;20(15):49. doi:10.1186/s12905-015-0201-6.
Schnyder U, Schnyder-Lüthi C, Ballinari P, Blaser A. Therapy for vaginismus: in vivo versus in vitro desensitization. Can J Psychiatry. 1998;43(9):941–4.
ter Kuile MM, Melles RJ, Tuijnman-Raasveld CC, de Groot HE, van Lankveld JJ. Therapist-aided exposure for women with lifelong vaginismus: mediators of treatment outcome: a randomized waiting list control trial. J Sex Med. 2015;12(8):1807–19. doi:10.1111/jsm.12935.. Epub 2015 Aug 6.
Lahaie MA, Boyer SC, Amsel R, Khalifé S, Binik YM. Vaginismus: a review of the literature on the classification/diagnosis, etiology and treatment. Womens Health (Lond). 2010;6(5):705–19. doi:10.2217/whe.10.46.
Ferreira JR, Souza RP. Botulinum toxin for vaginismus treatment. Pharmacology. 2012;89(5–6):256–9.
Ghazizadeh S, Nikzad M. Botulinum toxin in the treatment of refractory vaginismus. Obstet Gynecol. 2004;104(5 Pt 1):922.
Bertolasi L, Frasson E, Cappelletti JY, Vicentini S, Bordignon M, Graziottin A. Botulinum neurotoxin type A injections for vaginismus secondary to vulvar vestibulitis syndrome. Obstet Gynecol. 2009;114(5):1008–16. doi:10.1097/AOG.0b013e3181bb0dbb.
ter Kuile MM, Weijenborg PT. A cognitive-behavioral group program for women with vulvar vestibulitis syndrome (VVS): factors associated with treatment success. J Sex Marital Ther. 2006;32(3):199–213.
Engman M, Wijma K, Wijma B. Long-term coital behaviour in women treated with cognitive behaviour therapy for superficial coital pain and vaginismus. Cogn Behav Ther. 2010;39(3):193–202. doi:10.1080/16506070903571014.
ter Kuile MM, van Lankveld JJ, de Groot E, Melles R, Neffs J, Zandbergen M. Cognitive-behavioral therapy for women with lifelong vaginismus: process and prognostic factors. Behav Res Ther. 2007;45(2):359–73.
Akhavan-Taghavi MH, Asghari-Moghaddam MA, Froutan SK, Jadid-Milani M. Vaginismus in Iran: a single center report of 7 years experience. Nephrourol Mon. 2015;7(6):e30077. doi:10.5812/numonthly.30077.. eCollection 2015.
Munasinghe T, Goonaratna C, de Silva P. Couple characteristics and outcome of therapy in vaginismus. Ceylon Med J. 2004;49(2):54–7.
Ben-Zion I, Rothschild S, Chudakov M, Aloni R. Surrogate versus couple therapy in vaginismus. J Sex Med. 2007;4(3):728–33.
Labat JJ, Riant T, Robert R, Amarenco G, Lefaucheur JP, Rigaud J. Diagnostic criteria for pudendal neuralgia by pudendal nerve entrapment (Nantes criteria). Neurourol Urodyn. 2008;27(4):306–10.
Carmel M, Lebel M, Tu le M. Pudendal nerve neuromodulation with neurophysiology guidance: a potential treatment option for refractory chronic pelvi-perineal pain. Int Urogynecol J. 2010;21(5):613–6. doi:10.1007/s00192-009-1054-z.. Epub 2009 Dec 12.
Robert R, Labat JJ, Bensignor M, Glemain P, Deschamps C, Raoul S, Hamel O. Decompression and transposition of the pudendal nerve in pudendal neuralgia: a randomized controlled trial and long-term evaluation. Eur Urol. 2005;47(3):403–8.
Lee A, Bradford J, Fischer G. Long-term management of adult vulvar lichen sclerosus: a prospective cohort study of 507 women. JAMA Dermatol. 2015;151(10):1061–7. doi:10.1001/jamadermatol.2015.0643.
Chi CC, Kirtschig G, Baldo M, Brackenbury F, Lewis F, Wojnarowska F. Topical interventions for genital lichen sclerosus. Cochrane Database Syst Rev. 2011;7(12):CD008240. doi:10.1002/14651858.CD008240.pub2.
Burrows LJ, Creasey A, Goldstein AT. The treatment of vulvar lichen sclerosus and female sexual dysfunction. J Sex Mad. 2011;8(1):219–22.
Goldstein AT, Burrows LJ. Surgical treatment of clitoral phimosis caused by lichen sclerosus. Am J Obstet Gynecol. 2007;196(2):126.e1–4.
Gurumurthy M, Morah N, Gioffre G, Cruickshank ME. The surgical management of complications of vulval lichen sclerosus. Eur J Obstet Gynecol Reprod Biol. 2012;162(1):79–82.
Bradford J, Fischer G. Management of vulvovaginal lichen planus: a new approach. J Low Genit Tract Dis. 2013;17(1):28–32.
Goldstein A. Perineoplasty and vaginal advancement flap for vulvar granuloma fissuratum. J Sex Med. 2011;8(11):2984–7.
Palacios S, Castelo-Branco C, Currie H, Mijatovic V, Nappi RE, Simon J, Rees M. Update on management of genitourinary syndrome of menopause: a practical guide. Maturitas. 2015;82(3):308–13. doi:10.1016/j.maturitas.2015.07.020.. Epub 2015 Jul 26.
Palma F, Volpe A, Villa P, Cagnacci A, Writing group of AGATA study. Vaginal of women in postmenopause. Results from a multicentric observational study: The AGATA study atrophy. Maturitas. 2016;83:40–4.
North American Menopause Society. Management of symptomatic vulvovaginal atrophy: 2013 position statement of The American Menopause Society. Menopause. 2013;20(9):888–902.
Suckling J, Lethaby A, Kennedy R. Local oestrogen for vaginal atrophy in postmenopausal women. Cochrane Database Syst Rev. 2006;4:CD001500.
American College of Obstetricians and Gynecologists Committee Opinion. The Use of Vaginal Estrogen in Women With a History of Estrogen-Dependent Breast Cancer Number 659, March 2016 p. 618–9.
Simon JA, Lin VH, Radovich C, Bachmann GA, Ospemifene Study Group. One-year long-term safety extension study of ospemifene for the treatment of vulvar and vaginal atrophy in postmenopausal women with a uterus. Menopause. 2013;20(4):418–27. doi:10.1097/gme.0b013e31826d36ba.
Portman DJ, Labrie F, Archer DF, Bouchard C, Cusan L, Girard G, Ayotte N, Koltun W, Blouin F, Young D, Wade A, Martel C, Dubé R, Other participating members of VVA Prasterone Group. Lack of effect of intravaginal dehydroepiandrosterone (DHEA, prasterone) on the endometrium in postmenopausal women. Menopause. 2015;22(12):1289–95.
Goetsch MF, Lim JY, Caughey AB. A practical solution for dyspareunia in breast cancer survivors: a randomized controlled trial. J Clin Oncol. 2015;33(30):3394–400.
Perino A, Calligaro A, Forlani F, Tiberio C, Cucinella G, Svelato A, Saitta S, Calagna G. Vulvo-vaginal atrophy: a new treatment modality using thermo-ablative fractional CO2 laser. Maturitas. 2015;80(3):296–301.
Zondervan KT, Yudkin PL, Vessey MP, Jenkinson CP, Dawes MG, Barlow DH, Kennedy SH. Chronic pelvic pain in the community – symptoms, investigations, and diagnoses. Am J Obstet Gynecol. 2001;184(6):1149–55.
Diatchenko L, Nackley AG, Slade GD, Fillingim RB, Maixner W. Idiopathic pain disorders – pathways of vulnerability. Pain. 2006;123(3):226–30.
Stratton P, Khachikyan I, Sinaii N, Ortiz R, Shah J. Association of chronic pelvic pain and endometriosis with signs of sensitization and myofascial pain. Obstet Gynecol. 2015;125(3):719–28.
As-Sanie S, Kim J, Schmidt-Wilcke T, Sundgren PC, Clauw DJ, Napadow V, Harris RE. Functional connectivity is associated with altered brain chemistry in women with endometriosis-associated chronic pelvic pain. J Pain. 2016;17(1):1–13. doi:10.1016/j.jpain.2015.09.008.. Epub 2015 Oct 9.
Brawn J, Morotti M, Zondervan KT, Becker CM, Vincent K. Central changes associated with chronic pelvic pain and endometriosis. Hum Reprod Update. 2014;20(5):737–47.
Kavoussi SK, Lim CS, Skinner BD, Lebovic DI, As-Sanie S. New paradigms in the diagnosis and management of endometriosis. Curr Opin Obstet Gynecol. 2016;28(4):267–76.
Prentice A, Deary AJ, Bland E. Progestagens and anti-progestagens for pain associated with endometriosis. Cochrane Database Syst Rev. 2000;CD002122.
Brown J, Pan A, Hart RJ. Gonadotrophin-releasing hormone analogues for pain associated with endometriosis. Cochrane Database Syst Rev. 2010;8(12):CD008475.
Ferrero S, Gillott DJ, Venturini PL, Remorgida V. Use of aromatase inhibitors to treat endometriosis-related pain symptoms: a systematic review. Reprod Biol Endocrinol. 2011;9:89. doi:10.1186/1477-7827-9-89.
Muzii L, Di Tucci C, Achilli C, Di Donato V, Musella A, Palaia I, Panici PB. Continuous versus cyclic oral contraceptives after laparoscopic excision of ovarian endometriomas: a systematic review and metaanalysis. Am J Obstet Gynecol. 2016;214(2):203–11.
Deguara CS, Pepas L, Davis C. Does minimally invasive surgery for endometriosis improve pelvic symptoms and quality of life? Curr Opin Obstet Gynecol. 2012;24(4):241–4.
Fritzer N, Hudelist G. Love is a pain? Quality of sex life after surgical resection of endometriosis: a review. Eur J Obstet Gynecol Reprod Biol. 2016. pii: S0301-2115(16)30187-7.
Lukic A, Di Properzio M, De Carlo S, Nobili F, Schimberni M, Bianchi P, Prestigiacomo C, Moscarini M, Caserta D. Quality of sex life in endometriosis patients with deep dyspareunia before and after laparoscopic treatment. Arch Gynecol Obstet. 2016;293(3):583–90. doi:10.1007/s00404-015-3832-9.. Epub 2015 Aug 6.
Nourmoussavi M, Bodmer-Roy S, Mayji N, Williams C, ALlaire C, Yong PJ. Bladder base tenderness in etiology of deep dyspareunia. J Sex Med. 2014;12:3078–84.
Peters KM, Killinger KA, Carrico DJ, Ibrahim IA, Diokno AC, Grasiottin A. Sexual function and sexual distress in women with interstitial cystitis a case control study. Urology. 2007;70(3):543–7.
Mathias SD, Kuppermann M, Liberman RF, et al. Chronic pelvic pain: prevalence, health-related quality of life, and economic correlates. Obstet Gynecol. 1996;87:321Y327.
Doggweiler R, Whitmore KE, Meijlink JM, Drake MJ, Frawley H, Nordling J, Hanno P, Fraser MO, Homma Y, Garrido G, Gomes MJ, Elneil S, van de Merwe JP, Lin AT, Tomoe H. A standard for terminology in chronic pelvic pain syndromes: a report from the chronic pelvic pain working group of the international continence society. NeurourolUrodyn. 2016. doi:10.1002/nau.23072.. [Epub ahead of print].
Bogart LM, Suttorp MJ, Elliott MN, Clemens JQ, Berry SH. Prevalence and correlates of sexual dysfunction among women with bladder pain sydrome/interstitial cystitis. Female Urology. 2011;77(3):576–80.
Graziottin A. Sexual pain disorders: dyspareunia and vaginismus. Oxford: Blackwell; 2006. p. P342–35.International Society of Sexual Medicine. Chapter 25
Gardella B, Porru D, Ferdeghini F, Martinotti Gabellotti E, Nappi RE, Rovereto B, Spinillo A. Insight into urogynecologic features of women with interstitial cystitis/painful bladder syndrome. Eur Urol. 2008;54(5):1145–51. doi:10.1016/j.eururo.2008.01.079.. Epub 2008 Feb 6.
www.ichelp.org/TreatmentAndSelfHelp/ICAandDiet.html. Accessed 24 Jan 2012.
Fitzgerald MP, Anderson RU, Potts J, Payne CK, Peters KM, Clemens JQ, Kotarinos R, Fraser L, Cosby A, Fortman C, Neville C, Badillo S, Odabachian L, Sanfield A, O’Dougherty B, Halle-Podell R, Cen L, Chuai S, Landis JR, Mickelberg K, Barrell T, Kusek JW, Nyberg LM, Urological Pelvic Pain Collaborative Research Network. Randomized multicenter feasibility trial of myofascial physical therapy for the treatment of urological chronic pelvic pain syndromes. J Urol. 2013;189(1 Suppl):S75–85. doi:10.1016/j.juro.2012.11.018.
Hanno PM, Burks DA, Clemens JQ, et al. AUA guideline for the diagnosis and treatment of interstitial cystitis/bladder pain syndrome. J Urol. 2011;185:2162.
Foster Jr HE, Hanno PM, Nickel JC, et al. Effect of amitriptyline on symptoms in treatment naïve patients with interstitial cystitis/painful bladder syndrome. J Urol. 2010;183:1853.
van Ophoven A, Pokupic S, Heinecke A, Hertle L. A prospective, randomized, placebo controlled, double-blind study of amitriptyline for the treatment of interstitial cystitis. J Urol. 2004;172:533.
Thilagarajah R, Witherow RO, Walker MM. Oral cimetidine gives effective symptoms relief in painful bladder disease: a prospective, randomized double blind placebo controlled trial. BJU Int. 2001;87:207.
Seshadri P, Emerson L, Morales A. Cimetidine in the treatment of interstitial cystitis. Urology. 1994;44:614.
Dasgupta P, Sharma SD, Womack C, et al. Cimetidine in painful bladder syndrome: a histopathological study. BJU Int. 2001;88:183.
Nickel JC, Herschorn S, Whitmore KE, Forrest JB, Hu P, Friedman AJ, Baseman AS. Pentosan polysulfate sodium for treatment of interstitial cystitis/bladder pain syndrome: insights from a randomized, double-blind, placebo controlled study. J Urol. 2015;193(3):857–62. doi:10.1016/j.juro.2014.09.036.. Epub 2014 Sep 20.
Anderson VR, Perry CM. Pentosan polysulfate: a review of its use in the relief of bladder pain or discomfort in interstitial cystitis. Drugs. 2006;66(6):821–35.
Nickel JC, Parsons CL, Forrest J, Kaufman D, Evans R, Chen A, Wan G, Xiao X. Improvement in sexual functioning in patients with interstitial cystitis/painful bladder syndrome. J Sex Med. 2008;5(2):394–9 .Epub 2007 Dec 14
Welk BK, Teichman JM. Dyspareunia response in patients with interstitial cystitis treated withintravesical lidocaine, bicarbonate, and heparin. Urology. 2008;71(1):67–70. doi:10.1016/j.urology.2007.09.067.
Ottem DP, Teichman JM. What is the value of cystoscopy with hydrodistension for interstitial cystitis? Urology. 2005;66(3):494–9.
Jhang JF, Kuo HC. Novel treatment of chronic bladder pain syndrome and other pelvic pain disorders by Onabotulinumtoxin A injection. Toxins. 2015;7:2232–50.
Giannantoni A, Conte A, Farfariello V, Proietti S, Vianello A, Nardicchi V, Santoni G, Amantini C. Onabotulinumtoxin-A intradetrusorial injections modulate bladder expression of NGF, TrkA, p75 and TRPV1 in patients with detrusor overactivity. Pharmacol Res. 2013;68(1):118–24. doi:10.1016/j.phrs.2012.11.009.. Epub 2012 Dec 13.
Conte A, Giannantoni A, Proietti S, Giovannozzi S, Fabbrini G, Rossi A, Porena M, Berardelli A. Botulinum toxin A modulates afferent fibers in neurogenic detrusor overactivity. Eur J Neurol. 2012;19(5):725–32. doi:10.1111/j.1468-1331.2011.03618.x.. Epub 2011 Dec 28.
Kaya S, Hermans L, Willems T, Roussel N, Meeus M. Central sensitization in urogynecological chronic pelvic pain: A systematic literature review. Pain Physician. 2013;16:291–308.
Aoki KR. Evidence for antinociceptive activity of botulinum toxin type A in pain management. Headache. 2003;43(Suppl 1):S9–15.
Foran PG, Mohammed N, Lisk GO, Nagwaney S, Lawrence GW, Johnson E, Smith L, Aoki KR, Dolly JO. Evaluation of the therapeutic usefulness of botulinum neurotoxin B, C1, E, and F compared with the long lasting type A. Basis for distinct durations of inhibition of exocytosis in central neurons. J Biol Chem. 2003;278(2):1363–71 .Epub 2002 Oct 14
Durham PL, Cady R, Cady R. Regulation of calcitonin gene-related peptide secretion from trigeminal nerve cells by botulinum toxin type A: implications for migraine therapy. Headache. 2004;44(1):35–42 .discussion 42-3
Khera M, Somogyi GT, Kiss S, Boone TB, Smith CP. Botulinum toxin A inhibits ATP release from bladder urothelium after chronic spinal cord injury. Neurochem Int. 2004;45(7):987–93.
Nijs J, van Houdenhove B, Oostendorp RA. Recognition of central sensitization in patients with musculoskeletal pain: application of pain neurophysiology in manual therapy practice. Man Ther. 2010;15(2):135–41. doi:10.1016/j.math.2009.12.001.. Epub 2009 Dec 24.
Kuo HC, Chancellor MB. Comparison of intravesical botulinum toxin type A injections plus hydrodistention with hydrodistention alone for the treatment of refractory interstitial cystitis/painful bladder syndrome. BJU Int. 2009;104(5):657–61. doi:10.1111/j.1464-410X.2009.08495.x.. Epub 2009 Mar 30.
Kuo HC, Jiang YH, Tsai YC, Kuo YC. Intravesical botulinum toxin-A injection reduce bladder pain of interstital cystitis/bladder pain syndrome refractory to conventional treatment—A prospective, multicenter, randomized, double blind, placebo-controlled clinical trial. NeurourolUrodyn. 2016;35(5):609–14. doi:10.1002/nau.22760.. Epub 2015 Apr 24.
Marcelissen T, Jacobs R, van Kerrebroeck P, de Wachter S. Sacral neuromodulation as a treatment for chronic pelvic pain review article. J Urol. 2011;186(2):387–93.
Lombardi G, Finazzi Agrò E, Del Popolo G. Sacral neuromodulation and female sexuality. Int Urogynecol J. 2015;26(12):1751–7. doi:10.1007/s00192-015-2708-7.. Epub 2015 Apr 16.
Fass R, Fullerton S, Naliboff B, Hirsh T. Mayer EA sexual dysfunction in patients with irritable bowel syndrome and non-ulcer dyspepsia. Digestion. 1998;59(1):79–85.
Slocumb J. Neurological factors in chronic pelvic pain: trigger points and the abdominal pelvic pain syndrome. Am J Obstet Gynecol. 1984;149(5):536–43.
Tu FF, Holt J, Gonzales J, Fitzgerald CM. Physical theapy evaluation of patients with chronic pelvic pain: a controlled study. Am J Obstet Gynecol. 2008;198(3):272–7.
Mui J, Allaire C, Williams C, Yong PJ. Abdominal wall pain in women with chronic pelvic pain. J Obstet Gynaecol Can. 2016;38(2):154–9.
Annaswamy TM, De Luigi AJ, O’Neill BJ, Keole N, Berbrayer D. Emerging concepts in the treatment of myofascial pain: a review of medications, modalities, and needle-based interventions. PMR. 2011;3(10):940–61. doi:10.1016/j.pmrj.2011.06.013.
Nazareno J, Ponich T, Gregor J. Long-term follow-up of trigger point injections for abdominal wall pain. Can J Gastroenterol. 2005;19(9):561–5.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing AG
About this chapter
Cite this chapter
Rapkin, A., Masghati, S., Grisales, T. (2017). Treatment of Genito-Pelvic Pain/Penetration Disorder. In: IsHak, W. (eds) The Textbook of Clinical Sexual Medicine. Springer, Cham. https://doi.org/10.1007/978-3-319-52539-6_21
Download citation
DOI: https://doi.org/10.1007/978-3-319-52539-6_21
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-52538-9
Online ISBN: 978-3-319-52539-6
eBook Packages: MedicineMedicine (R0)